Deciphering the signature of selective constraints on cancerous mitochondrial genome

Molecular Biology and Evolution

Volumn 29, Issue 4, 2012, Pages 1255-1261

  Liu, Jia ^a,b,c   Wang, Li Dong ^d   Sun, Yan Bo ^a,b,c   Li, En Min ^e   Xu, Li Yan ^e   Zhang, Ya Ping ^a,b,f   Yao, Yong Gang ^a   Kong, Qing Peng ^a,b  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d ZHENGZHOU UNIVERSITY   (China)

^e SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^f YUNNAN UNIVERSITY   (China)

Author keywords

cancer; mitochondrial genome; selective constraints; somatic mutation

Indexed keywords

MITOCHONDRIAL DNA;

AEROBIC CAPACITY; ARTICLE; CANCER CELL; CANCER GENETICS; CANCER PATIENT; CARCINOGENESIS; CONSTRAINT INDUCED THERAPY; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE MUTATION; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOCHONDRIAL GENOME; MITOCHONDRIAL RESPIRATION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; POINT MUTATION; TUMOR GENE;

BASE SEQUENCE; DATABASES, GENETIC; DNA, MITOCHONDRIAL; ESOPHAGEAL NEOPLASMS; GENOME, MITOCHONDRIAL; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; SELECTION, GENETIC;

EID: 84863365961     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msr290     Document Type: Article

References (38)

1. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. 1999. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 23:147. (Pubitemid 29455385)
2. Bandelt HJ, Achilli A, Kong QP, Salas A, Lutz-Bonengel S, Sun C, Zhang YP, Torroni A, Yao YG. 2005. Low "penetrance" of phylogenetic knowledge in mitochondrial disease studies. Biochem Biophys Res Commun. 333:122-130. (Pubitemid 40823022)
3. Bandelt HJ, Lahermo P, Richards M, Macaulay V. 2001. Detecting errors in mtDNA data by phylogenetic analysis. Int J Legal Med. 115:64-69. (Pubitemid 33009609)
4. Bandelt HJ, Salas A, Taylor RW, Yao YG. 2009. Exaggerated status of "novel" and "pathogenic" mtDNA sequence variants due to inadequate database searches. Hum Mutat. 30:191-196.
5. Brandon M, Baldi P, Wallace DC. 2006. Mitochondrial mutations in cancer. Oncogene 25:4647-4662. (Pubitemid 44187615)
6. Chandra D, Singh KK. 2011. Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta. 1807:620-625.
7. Chatterjee A, Mambo E, Sidransky D. 2006. Mitochondrial DNA mutations in human cancer. Oncogene 25:4663-4674. (Pubitemid 44187616)
8. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG. 2001. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet. 28:147-150. (Pubitemid 32538059)
9. Crespi BJ, Summers K. 2006. Positive selection in the evolution of cancer. Biol Rev Camb Philos Soc. 81:407-424. (Pubitemid 44092345)
10. Felsenstein J. 2009. PHYLIP (phylogeny inference package) version 3.69. Seattle (WA): Department of Genome Sciences, University of Washington.
11. Fendt L, Zimmermann B, Daniaux M, Parson W. 2009. Sequencing strategy for the whole mitochondrial genome resulting in high quality sequences. BMC Genomics 10:139.
12. Gochhait S, Bhatt A, Sharma S, Singh YP, Gupta P, Bamezai RN. 2008. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development-a study in north Indian sporadic breast and esophageal cancer patients. Int J Cancer. 123:2580-2586.
13. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
14. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. 2008. ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661-664. (Pubitemid 351928347)
15. Kong QP, Bandelt HJ, Sun C, et al. (12 co-authors). 2006. Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet. 15:2076-2086. (Pubitemid 43923397)
16. Kong QP, Salas A, Sun C, Fuku N, Tanaka M, Zhong L, Wang CY, Yao YG, Bandelt HJ. 2008. Distilling artificial recombinants from large sets of complete mtDNA genomes. PLoS One 3:e3016.
17. Kong QP, Yao YG, Sun C, Bandelt HJ, Zhu CL, Zhang YP. 2003. Phylogeny of east Asian mitochondrial DNA lineages inferred from complete sequences. Am J Hum Genet. 73:671-676. (Pubitemid 37076281)
18. Lassmann T, Frings O, Sonnhammer EL. 2009. Kalign2: highperformance multiple alignment of protein and nucleotide sequences allowing external features. Nucleic Acids Res. 37:858-865.
19. McDonald JH, Kreitman M. 1991. Adaptive protein evolution at the Adh locus in Drosophila. Nature 351:652-654. (Pubitemid 21896661)
20. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
21. Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, Khan F, Wang CY, Chaudhuri TK, Palla V, Zhang YP. 2004. Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet. 75:966-978. (Pubitemid 39532067)
22. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, Bandelt HJ. 2005. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2:e296.
23. Stafford P, Chen-Quin EB. 2010. The pattern of natural selection in somatic cancer mutations of human mtDNA. J Hum Genet. 55:605-612.
24. Sun C, Kong QP, Palanichamy MG, Agrawal S, Bandelt HJ, Yao YG, Khan F, Zhu CL, Chaudhuri TK, Zhang YP. 2006. The dazzling array of basal branches in the mtDNA macrohaplogroup M from India as inferred from complete genomes. Mol Biol Evol. 23:683-690. (Pubitemid 43278280)
25. Tan DJ, Chang J, Liu LL, Bai RK, Wang YF, Yeh KT, Wong LJ. 2006. Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer. BMC Cancer 6:93.
26. van Oven M, Kayser M. 2009. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 30:E386-E394.
27. Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033.
28. Wallace DC. 2005. Mitochondria and cancer: Warburg addressed. Cold Spring Harb Symp Quant Biol. 70:363-374. (Pubitemid 44124891)
29. Wang CY, Li H, Hao XD, Liu J, Wang JX, Wang WZ, Kong QP, Zhang YP. 2011. Uncovering the profile of somatic mtDNA mutations in Chinese colorectal cancer patients. PLoS One 6:e21613.
30. Wang CY, Wang HW, Yao YG, Kong QP, Zhang YP. 2007. Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer. 121:1253-1256.
31. Warburg O. 1956. On respiratory impairment in cancer cells. Science 124:269-270.
32. Yao YG, Bravi CM, Bandelt HJ. 2004. A call for mtDNA data quality control in forensic science. Forensic Sci Int. 141:1-6. (Pubitemid 38446830)
33. Yao YG, Kong QP, Salas A, Bandelt HJ. 2008. Pseudomitochondrial genome haunts disease studies. J Med Genet. 45: 769-772.
34. Yao YG, Macauley V, Kivisild T, Zhang YP, Bandelt HJ. 2003. To trust or not to trust an idiosyncratic mitochondrial data set. Am J Hum Genet. 72:1341-1346.
35. Yao YG, Salas A, Bravi CM, Bandelt HJ. 2006. A reappraisal of complete mtDNA variation in East Asian families with hearing impairment. Hum Genet. 119:505-515.
36. Yao YG, Salas A, Logan I, Bandelt HJ. 2009. mtDNA data mining in GenBank needs surveying. Am J Hum Genet. 85:929-933.
37. Zhidkov I, Livneh EA, Rubin E, Mishmar D. 2009. MtDNA mutation pattern in tumors and human evolution are shaped by similar selective constraints. Genome Res. 19:576-580.
38. Zhou S, Kachhap S, Sun W, et al. (18 co-authors). 2007. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci USA. 104:7540-7545. (Pubitemid 47185942)